PMID: 7514366Jun 1, 1994

Risperidone in the treatment of schizophrenia

The American Journal of Psychiatry
S R Marder, R C Meibach

Abstract

The purpose of this study was to investigate the safety and efficacy of risperidone in the treatment of schizophrenic patients and determine its optimal dose. This double-blind study included 388 schizophrenic patients drawn from 20 sites in the United States. Patients were randomly assigned to 8 weeks' treatment with placebo, one of four doses of risperidone (2, 6, 10, or 16 mg), or 20 mg of haloperidol daily. Clinical improvement (20% reduction in total scores on the Positive and Negative Syndrome Scale for Schizophrenia) at the study end point was shown by 35% of the patients receiving 2 mg of risperidone, 57% receiving 6 mg, 40% receiving 10 mg, and 51% receiving 16 mg; and by 30% receiving haloperidol and 22% receiving placebo. Statistically significant differences in clinical improvement were found between 6 and 16 mg of risperidone versus placebo and versus haloperidol. Positive symptom scores were significantly lower after 6, 10, and 16 mg of risperidone and 20 mg of haloperidol than placebo; negative symptom scores, however, were reduced significantly, compared with placebo, only after 6 and 16 mg of risperidone. The incidence of extra-pyramidal side effects (measured by the Extrapyramidal Symptom Rating Scale) was sig...Continue Reading

References

Jul 27, 2002·Psychopharmacology·R S Kahn
Mar 24, 2000·Journal of the American Medical Informatics Association : JAMIA·L A LenertR Mahmoud
Jul 21, 1998·Journal of Affective Disorders·M A FryeR M Post
Feb 26, 2004·Controlled Clinical Trials·Tony VangeneugdenGeert Molenberghs
Apr 13, 2005·Clinical Therapeutics·Erin Danielle Knox, Glen L Stimmel
Oct 6, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S KasperA Heiden
Oct 6, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J M Kane
Feb 7, 1998·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·D J King
Jan 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·R G McCreadie
Jan 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·G BondolfiH Dufour
May 1, 1997·Journal of Clinical Pharmacology·P F Buckley
Jan 5, 2001·European Child & Adolescent Psychiatry·Helmut RemschmidtEberhard Schulz
Sep 10, 2008·Journal of Neural Transmission·Christian FleischhakerAndreas Warnke
Jan 31, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jovan SimeonSelena Walker
Dec 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Vladimir LernerRael D Strous
Jan 31, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yung-Chieh YenMian-Yoon Chong
Jan 31, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Takefumi SuzukiHaruo Kashima
Jun 17, 2003·Journal of the American Medical Directors Association·Richard J Goldberg
Oct 19, 2012·Surgical Endoscopy·Eu Jin TanKee Yuan Ngiam
Jan 1, 1995·Acta Psychiatrica Scandinavica. Supplementum·H J Möller
Jan 1, 1995·Acta Psychiatrica Scandinavica. Supplementum·J P Lindenmayer
Jul 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·I Fras, L F Major
Apr 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·W C Lykes, J E Cueva
Nov 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·A HardanB Hrecznyj
May 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·J L ArmenterosJ Gorman
May 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·S KumraD Grothe
May 15, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·S GuptaS Madhusoodanan
Apr 13, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·R L FindlingJ L Blumer
Dec 4, 1998·Biological Psychiatry·G TsaiJ T Coyle
Aug 1, 1996·European Journal of Nuclear Medicine·G F Busatto
Jan 13, 1999·Pediatric Clinics of North America·R L FindlingJ L Blumer

Related Concepts

Antipsychotic Effect
Schizophrenia
Piperidines
Isoxazoles
Haldol
Schizophrenic Psychology
Factor Construct Rating Scales (Fcrs)
Placebos
Double-Blind Method
Drug Administration Schedule

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Sexual Dimorphism in Neurodegeneration

There exist sex differences in neurodevelopmental and neurodegenerative disorders. For instance, multiple sclerosis is more common in women, whereas Parkinson’s disease is more common in men. Here is the latest research on sexual dimorphism in neurodegeneration

HLA Genetic Variation

HLA genetic variation has been found to confer risk for a wide variety of diseases. Identifying these associations and understanding their molecular mechanisms is ongoing and holds promise for the development of therapeutics. Find the latest research on HLA genetic variation here.

Super-resolution Microscopy

Super-resolution microscopy is the term commonly given to fluorescence microscopy techniques with resolutions that are not limited by the diffraction of light. Here are the latest discoveries pertaining to super-resolution microscopy.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Brain Lower Grade Glioma

Low grade gliomas in the brain form from oligodendrocytes and astrocytes and are the slowest-growing glioma in adults. Discover the latest research on these brain tumors here.

CD4/CD8 Signaling

Cluster of differentiation 4 and 8 (CD8 and CD8) are glycoproteins founds on the surface of immune cells. Here is the latest research on their role in cell signaling pathways.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

© 2020 Meta ULC. All rights reserved